Question of the Day – Monday January 30, 2017
Question: The recognition of chemicals as potential carcinogens had its inception with observations made by Sir Percival Pott in the 1770’s. What was this individual’s contribution to the science of chemical carcinogenesis?
Question of the Day – Friday January 27, 2017
Question: What are the primary environmental sources for the chemical sulfur dioxide?
Question of the Day – Wednesday January 25, 2017
Question: Who were the “radium girls”?
Question of the Day – Tuesday January 24, 2017
Question: What is the classic presentation of tick paralysis?
Question of the Day – Monday January 23, 2017
Question: What is “nanging” and what clinical symptoms may result from repeated nanging?
Question of the Day – Friday January 20, 2017
Question: Individuals requiring chronic transfusion therapy are often treated with the iron chelator deferoxamine in order to address transfusion-induced hemochromatosis and associated complications. Which toxicities have been associated with the use of deferoxamine?
Question of the Day – Thursday January 19, 2017
Question: MEK inhibitors (inhibit the mitogen- activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) kinase) are a relatively new class of chemotherapeutic agents used in the treatment of a variety of metastatic cancers. These agents have been associated with the development of ocular toxicity. What is the nature of this toxicity?
Question of the Day – Wednesday January 18, 2017
Question: What is the elimination half-life of smoked crystal methamphetamine?
Question of the Day – Tuesday January 17, 2017
Question: How do electronic cigarettes produce the vapor inhaled by users of these products?